Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of Istradefylline (KW-6002) as Monotherapy in Parkinson's Disease (PD) Patients

This study has been completed.
Information provided by:
Kyowa Kirin Pharmaceutical Development, Inc. Identifier:
First received: September 12, 2005
Last updated: July 12, 2016
Last verified: July 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2006
  Primary Completion Date: July 2006 (Final data collection date for primary outcome measure)